COMPASS THERAPEUTICS INC

Compass Therapeutics is a clinical-stage biopharmaceutical company whose core business model involves the development of proprietary antibody-based therapeutics. This research and development process inherently requires animal testing to establish the safety and efficacy of its drug candidates before they can proceed to human clinical trials. The company’s pipeline, focused on oncology treatments, is built on preclinical data generated from animal studies.

While specific details on the scale or nature of Compass Therapeutics' animal testing are not publicly disclosed in the gathered evidence, the use of animals is a standard, material, and unavoidable component of its business. As a company advancing antibody therapies, its preclinical research would involve testing on laboratory animals. No public commitment to alternative, non-animal testing methods or a phase-out of animal use was found in the available materials.